Table 2. Numbers of participants at each visit.
NC | MCI | AD | ||||
---|---|---|---|---|---|---|
Follow-up visits | Non-aspirin users | Aspirin users | Non-aspirin users | Aspirin users | Non-aspirin users | Aspirin users |
Baseline | 310 | 199 | 586 | 399 | 231 | 141 |
1 y | 246 | 160 | 510 | 362 | 176 | 112 |
2 y | 230 | 149 | 407 | 283 | 106 | 65 |
3 y | 139 | 78 | 348 | 228 | 5 | 5 |
4 y | 137 | 98 | 238 | 168 | 1 | 1 |
5 y | 86 | 48 | 157 | 105 | 1 | 1 |
6 y | 109 | 79 | 128 | 88 | 0 | 2 |
7 y | 85 | 54 | 97 | 78 | / | / |
8 y | 68 | 46 | 69 | 49 | / | / |
9 y | 43 | 16 | 33 | 26 | / | / |
10 y | 29 | 17 | 17 | 11 | / | / |
11 y | 26 | 12 | 8 | 9 | / | / |
12 y | 20 | 8 | 7 | 7 | / | / |
13 y | 22 | 9 | 3 | 2 | / | / |
14 y | 5 | 3 | 1 | 0 | / | / |
Abbreviations: CN: normal cognition; MCI: mild cognitive impairment; AD: Alzheimer’s disease.